Skip to main content

Published locations for Tirzepatide succeeds in obesity in SURMOUNT-1, says Lilly

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Tirzepatide succeeds in obesity in SURMOUNT-1, says Lilly

User login

  • Reset your password
  • /content/tirzepatide-succeeds-obesity-surmount-1-says-lilly
  • /clinicianreviews/article/254244/obesity/tirzepatide-succeeds-obesity-surmount-1-says-lilly
  • /familypracticenews/article/254244/obesity/tirzepatide-succeeds-obesity-surmount-1-says-lilly
  • /internalmedicinenews/article/254244/obesity/tirzepatide-succeeds-obesity-surmount-1-says-lilly
  • /clinicalendocrinologynews/article/254244/obesity/tirzepatide-succeeds-obesity-surmount-1-says-lilly
  • /ecardiologynews/article/254244/obesity/tirzepatide-succeeds-obesity-surmount-1-says-lilly
  • /cardiology/article/254244/obesity/tirzepatide-succeeds-obesity-surmount-1-says-lilly
  • /endocrinology/article/254244/obesity/tirzepatide-succeeds-obesity-surmount-1-says-lilly
  • /internalmedicine/article/254244/obesity/tirzepatide-succeeds-obesity-surmount-1-says-lilly
  • /familymedicine/article/254244/obesity/tirzepatide-succeeds-obesity-surmount-1-says-lilly
  • /type-2-diabetes-icymi/article/254244/obesity/tirzepatide-succeeds-obesity-surmount-1-says-lilly